Cahill Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
WA
Cahill Financial Advisors's IBB Position: Q2 2026 in Review
Cahill Financial Advisors reduced its iShares Biotechnology ETF (IBB) stake by 4.1% in Q2 2026, selling an estimated $9.97K and leaving 1,370 shares worth $261K. The position accounts for 0.03% of the portfolio, ranked #267.
Cahill Financial Advisors first reported a position in IBB in Q3 2017 and has held it in 19 quarters since. The position peaked at $519K in Q4 2022. 731 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Cahill Financial Advisors held 1,370 shares of iShares Biotechnology ETF worth $261K as of Q2 2026.
- Cahill Financial Advisors sold 58 iShares Biotechnology ETF shares in Q2 2026, an estimated $9.97K.
- iShares Biotechnology ETF made up 0.03% of Cahill Financial Advisors's portfolio in Q2 2026, its #267 holding.
- Cahill Financial Advisors first reported a position in iShares Biotechnology ETF in Q3 2017 and has held it in 19 quarters since.
- Cahill Financial Advisors's iShares Biotechnology ETF position peaked at $519K in Q4 2022.
- 731 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Cahill Financial Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.